To access this material please log in or register

Register Authorize

Compliance with prescribed therapy and treatment efficacy in patients with chronic coronary disease: State-of-the-art and ways of the problem solution

Gilyarevsky S. R.
State Budgetary Educational Institution of Advanced Professional Education, "Russian Medical Academy of Postgraduate Education" of the Ministry of Health of the Russian Federation, Barrikadnaya 2/1, Moscow 123995

Keywords: coronary disease, treatment regimen, treatment compliance

DOI: 10.18087/rhj.2016.6.2286

The article focuses on issues of insufficient compliance with the treatment regimen of patients with coronary disease (CD); discusses results of a meta-analysis of different interventions for increasing therapy compliance of such patients; provides results of the first large observational study, which evaluated the relationship between therapy compliance and mortality of patients with CD; and discusses the effect of dosage frequency on the degree of therapy compliance.
  1. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a costeffectiveness analysis. Lancet. 2006 Aug 19;368 (9536):679–86.
  2. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016 Aug 14; pii:ehw334. [Epub ahead of print]
  3. Maddox TM, Chan PS, Spertus JA, Tang F, Jones P, Ho PM et al. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Feb 18;63 (6):539–46.
  4. Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK. A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med. 2011 Dec;26 (12):1479–91.
  5. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation. 2009 Jun 16;119 (23):3028–35.
  6. Hamood H, Hamood R , Green MS, Almog R . Determinants of adherence to evidence-based therapy after acute myocardial infarction. Eur J Prev Cardiol. 2016 Jun;23 (9):975–85.
  7. O’Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 2006 Sep 25;166 (17):1802–4.
  8. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012 May;73 (5):691–705.
  9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353 (5):487–97.
  10. Kolandaivelu K, Leiden BB, O’Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014 Dec 7;35 (46):3267–76.
  11. Nieuwlaat R , Schwalm JD, Khatib R , Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J. 2013 May;34 (17):1262–9.
  12. Chowdhury R , Khan H, Heydon E, Shroufi A, Fahimi S, Moore C et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013 Oct;34 (38):2940–8.
  13. Bansilal S, Castellano JM, Garrido E, Wei HG, Freeman A, Spetteii C et al. Assessing the impact of medication adherence on long-term cardiovascular outcomes. J Am Coll Cardiol. 2016 Aug 23;68 (8):789–801.
  14. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013 Oct;34 (38):2949–3003.
  15. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SCJr, Hoffman E et al. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med. 2013 Aug;126 (8):693–700.e1.
  16. Santo K, Kirkendall S, Laba TL, Thakkar J, Webster R , Chalmers J et al. Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials. Eur J Prev Cardiol. 2016 Jul;23 (10):1065–76.
  17. Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011 May 9;171 (9):814–22.
  18. Castellano JM, Sanz G, Pecalvo JL, Bansilal S, Fernandez-Ortiz A, Alvarez L et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol. 2014 Nov 18–25;64 (20):2071–82.
  19. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD004371.
  20. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 Apr 16; (2):CD000011.
  21. Caldeira D, Vaz-Carneiro A, Costa J. The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis. Rev Port Cardiol. 2014 Jul-Aug;33 (7-8):431–7.
  22. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006 Sep 25;166 (17):1842–7.
  23. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug 13;2 (8607):349–60.
  24. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009 Sep 10;361 (11):1045–57.
  25. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH et al. Creactive protein levels and outcomes after statin therapy. N Engl J Med. 2005 Jan 6;352 (1):20–8.
  26. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008 Feb 26;117 (8):1028–36.
  27. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 Sep 22;304 (12):1350–7.
Gilyarevsky S.R. Compliance with prescribed therapy and treatment efficacy in patients with chronic coronary disease: State-of-the-art and ways of the problem solution. Russian Heart Journal. 2016;15 (6):391–397

To access this material please log in or register

Register Authorize
Ru En